Discontinued — last reported Q3 '23
Axon Enterprise, Inc. Acquisitions decreased by 11.9% to $549.68M in Q1 2026 compared to the prior quarter. Over 2 years (FY 2022 to FY 2025), Acquisitions shows an upward trend with a 1653.4% CAGR.
High spending indicates an aggressive growth or diversification strategy, while low spending suggests a focus on organic growth or internal consolidation.
This metric tracks the cash paid to acquire other businesses or business units, net of any cash acquired in the transact...
Varies significantly based on M&A cycles; peers in the healthcare sector frequently use acquisitions to gain access to new diagnostic or therapeutic technologies.
acquisitions| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $21.69M | $526.00K | $526.00K | $526.00K | $526.00K | $64.00K | $237.77M | $25.00K | $0.00 | $384.02M | $0.00 | $3.81M | $19.00M | $624.07M | $549.68M |
| QoQ Change | — | -97.6% | +0.0% | +0.0% | +0.0% | -87.8% | >999% | -100.0% | -100.0% | — | -100.0% | — | +398.8% | >999% | -11.9% |
| YoY Change | — | — | — | — | -97.6% | -87.8% | — | — | -100.0% | — | -100.0% | >999% | — | +62.5% | — |